RXO:NYSERXO, Inc. Analysis
Data as of 2026-04-29 - not real-time
$19.52
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
RXO is trading at $19.52, hugging the 20‑day resistance of $20.18 while the 14‑day RSI sits at a lofty 76, flagging an overbought condition. Technical indicators remain bullish – the 20‑day SMA (17.26) sits above both the 50‑day (15.48) and 200‑day (15.33) averages, and the MACD line is above its signal, suggesting momentum could linger in the short run.
However, the fundamentals tell a different story: revenue fell 12% YoY, margins are thin (gross 16.4%, operating –0.6%), and the company is heavily leveraged with $670 M of debt against just $17 M of cash. The forward PE of 49.8 and analyst median target of $16 imply the stock is overvalued relative to earnings expectations, and the upcoming Q1 earnings release on May 7 will be a critical catalyst. The extreme greed sentiment (F&G index 89.6) adds a behavioral risk layer, while high beta (≈2.7) and 30‑day volatility of 46.7% underscore price swing potential.
However, the fundamentals tell a different story: revenue fell 12% YoY, margins are thin (gross 16.4%, operating –0.6%), and the company is heavily leveraged with $670 M of debt against just $17 M of cash. The forward PE of 49.8 and analyst median target of $16 imply the stock is overvalued relative to earnings expectations, and the upcoming Q1 earnings release on May 7 will be a critical catalyst. The extreme greed sentiment (F&G index 89.6) adds a behavioral risk layer, while high beta (≈2.7) and 30‑day volatility of 46.7% underscore price swing potential.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price near resistance and overbought RSI
- Negative earnings and shrinking margins
- High volatility and beta amplifying downside risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Upcoming earnings will clarify operating cash flow trends
- Forward EPS improvement vs current loss
- Debt load limiting operational flexibility
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Asset‑light model offers upside if freight volumes recover
- Persistent leverage and cash constraints
- Valuation gap to analyst targets suggests limited upside at current price
Key Metrics & Analysis
Financial Health
Revenue Growth-11.90%
Profit Margin-1.74%
P/E Ratio49.8
ROE-6.34%
ROA-0.13%
Debt/Equity43.48
P/B Ratio2.1
Op. Cash Flow$51.0M
Free Cash Flow$42.8M
Industry P/E30.8
Technical Analysis
TrendBullish
RSI76.2
Support$13.91
Resistance$20.18
MA 20$17.26
MA 50$15.48
MA 200$15.33
MACDBullish
VolumeStable
Fear & Greed Index89.59
Valuation
Target Price$16.06
Upside/Downside-17.71%
GradeOvervalued
TypeBlend
Risk Assessment
Beta2.69
Volatility46.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.